118 related articles for article (PubMed ID: 11401324)
1. Tumour enhancement with newly developed Mn-metalloporphyrin (HOP-9P) in magnetic resonance imaging of mice.
Takehara Y; Sakahara H; Masunaga H; Isogai S; Kodaira N; Takeda H; Saga T; Nakajima S; Sakata I
Br J Cancer; 2001 Jun; 84(12):1681-5. PubMed ID: 11401324
[TBL] [Abstract][Full Text] [Related]
2. Tumor enhancement using Mn-metalloporphyrin in mice: magnetic resonance imaging and histopathologic correlation.
Nasu H; Takehara Y; Isogai S; Kodaira N; Takeda H; Saga T; Nakajima S; Sakata I; Sakahara H
J Magn Reson Imaging; 2004 Aug; 20(2):294-9. PubMed ID: 15269956
[TBL] [Abstract][Full Text] [Related]
3. Assessment of a potential tumor-seeking manganese metalloporphyrin contrast agent in a mouse model.
Takehara Y; Sakahara H; Masunaga H; Isogai S; Kodaira N; Sugiyama M; Takeda H; Saga T; Nakajima S; Sakata I
Magn Reson Med; 2002 Mar; 47(3):549-53. PubMed ID: 11870842
[TBL] [Abstract][Full Text] [Related]
4. Metalloporphyrin enhancement of magnetic resonance imaging of human tumor xenografts in nude mice.
Furmanski P; Longley C
Cancer Res; 1988 Aug; 48(16):4604-10. PubMed ID: 3396012
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced high resolution magnetic resonance imaging of pigmented malignant melanoma using Mn-TPPS4 and Gd-DTPA: experimental results.
Mäurer J; Strauss A; Ebert W; Bauer H; Felix R
Melanoma Res; 2000 Feb; 10(1):40-6. PubMed ID: 10711639
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of [Gd(Bz-TTDA)]2- as a potential contrast agent in MR imaging of the hepatobiliary system: an animal study.
Hsu JS; Jaw TS; Liu GC; Wang YM; Chen SH; Kuo YT; Jao JC; Li CW; Tsai KB
J Magn Reson Imaging; 2004 Oct; 20(4):632-9. PubMed ID: 15390149
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Motexafin gadolinium (MGd) as a contrast agent for intraoperative MRI.
Hirschberg H; Wu GN; Madsen SJ
Minim Invasive Neurosurg; 2007 Dec; 50(6):318-23. PubMed ID: 18210352
[TBL] [Abstract][Full Text] [Related]
8. T1 efficacy of EVP-ABD: a potential manganese-based MR contrast agent for hepatic vascular and tissue phase imaging.
Zuo CS; Seoane P; Lanigan T; Harnish P; Prasad PV; Storey P; Li W; Rofsky NM
J Magn Reson Imaging; 2002 Dec; 16(6):668-75. PubMed ID: 12451580
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of manganese carbonate particles for magnetic resonance imaging of the liver.
Wisner ER; Merisko-Liversidge E; Kellar K; Katzberg RW; Karpinski PH; Amparo EG; Drake C; Griffey SM; Brock JM
Acad Radiol; 1995 Feb; 2(2):140-7. PubMed ID: 9419538
[TBL] [Abstract][Full Text] [Related]
10. Targeted magnetic resonance imaging with intraperitoneal and intravenous streptavidin (SA)-DTPA-Gd: a comparative study in tumor-bearing nude mice.
Ye J; Xu YK; Liu X; Lü GS
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):139-43. PubMed ID: 16503514
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of manganese in the brain of mice after intravenous injection of manganese-based contrast agents.
Gallez B; Baudelet C; Adline J; Geurts M; Delzenne N
Chem Res Toxicol; 1997 Apr; 10(4):360-3. PubMed ID: 9114970
[TBL] [Abstract][Full Text] [Related]
12. Metalloporphyrin contrast agents for magnetic resonance imaging of human tumors in mice.
Patronas NJ; Cohen JS; Knop RH; Dwyer AJ; Colcher D; Lundy J; Mornex F; Hambright P; Sohn M; Myers CE
Cancer Treat Rep; 1986 Mar; 70(3):391-5. PubMed ID: 3955550
[TBL] [Abstract][Full Text] [Related]
13. [Application of biotin-avidin system in targeted magnetic resonance imaging].
Liu X; Xu YK; Ye J
Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1130-2. PubMed ID: 15485783
[TBL] [Abstract][Full Text] [Related]
14. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
15. [Gadolinium-loaded nanoparticle as a novel molecular imaging contrast agent for magnetic resonance imaging].
Liu LZ; Guo GJ; Zeng MS; Lü YC; Liu XW; Cui CY; Wu PH; Li L
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):240-3. PubMed ID: 17425867
[TBL] [Abstract][Full Text] [Related]
16. Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy.
Li G; Slansky A; Dobhal MP; Goswami LN; Graham A; Chen Y; Kanter P; Alberico RA; Spernyak J; Morgan J; Mazurchuk R; Oseroff A; Grossman Z; Pandey RK
Bioconjug Chem; 2005; 16(1):32-42. PubMed ID: 15656573
[TBL] [Abstract][Full Text] [Related]
17. Role of exocrine cells in pancreatic enhancement using Mn-DPDP-enhanced MR imaging.
Gong J; Xu J; Zhou K; Shen K
Chin Med J (Engl); 2002 Sep; 115(9):1363-6. PubMed ID: 12411113
[TBL] [Abstract][Full Text] [Related]
18. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
[TBL] [Abstract][Full Text] [Related]
19. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
20. High-dose Gd-DTPA vs. Bis-Gd-mesoporphyrin for monitoring laser-induced tissue necrosis.
Bremer C; Bankert J; Filler T; Ebert W; Tombach B; Reimer P
J Magn Reson Imaging; 2005 Jun; 21(6):801-8. PubMed ID: 15906334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
